Spots Global Cancer Trial Database for Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging

Official Title: MAGIK: Using Implanted Markers to Determine the Feasibility of Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging: A Phase I Interventional Study of Lung Cancer Radiotherapy

Study ID: NCT04086082

Conditions

Lung Cancer

Interventions

Markerless Image Guidance

Study Description

Brief Summary: This trial will investigate the feasibility of the Markerless Tumour Tracking technology.

Detailed Description: Markerless Tumour Tracking will be integrated with existing treatment machines to provide real-time monitoring of tumour motion during treatment delivery. Eligible patients will be implanted with fiducial markers, which act as the ground truth for evaluating the accuracy of Markerless Tumour Tracking. The patients will undergo the current standard of care radiotherapy, with the exception that kilovoltage x-ray images will be acquired continuously during treatment delivery to enable Markerless Tumour Tracking.